beta

You're viewing our new website - find out more

Publication - Consultation Paper

Hepatobiliary and pancreatic cancer quality performance indicators: consultation review

Published: 16 Jan 2017
Part of:
Health and social care
ISBN:
9781786527387

Formal review and consultation on NHS Scotland's hepatobiliary and pancreatic (HBP) cancer quality performance indicators (QPIs).

40 page PDF

787.2kB

40 page PDF

787.2kB

Contents
Hepatobiliary and pancreatic cancer quality performance indicators: consultation review
8. Areas for Future Consideration

40 page PDF

787.2kB

8. Areas for Future Consideration

The HPB Cancer QPI Groups have not been able to identify sufficient evidence, or determine appropriate measurability specifications, to address all areas felt to be of key importance in the treatment of HPB cancer, and therefore in improving the quality of care for patients affected by HPB cancer.

The following areas for future consideration have been raised across the lifetime of the HPB Cancer QPIs.

  • Surveillance and screening of patients with chronic liver disease for the development of hepatocellular carcinoma.
  • Specialist pathology reporting for hepatocellular carcinoma.
  • Palliative chemotherapy for pancreatic cancer.
  • Surgical volumes for resection of primary liver cancer.
  • Timing and outcomes of biliary intervention in patients with malignant biliary obstruction.
  • Surgical margin rates

Contact

Email: Chris Booth